Product Images Ziprasidone Hydrochloride

Ziprasidone HCl is a medication with the NDC code S8180:33107. Unfortunately, the rest of the text is not legible or relevant.*

This is a medication description for a capsule containing 20mg of ziprasidone hydrochloride monohydrate USP. The dosage instructions are not available, but the storage conditions are specified as 25°C (77°F) with excursions permitted between 15° to 30°C (59° to 86°F). The manufacturer is identified as Lupin Pharmaceuticals, Inc. The medication is meant to be dispensed by a pharmacist with a patient information leaflet, and the capsules were manufactured in Pithampur, India.*

This is a medication label for Ziprasidone HCI capsules with NDC 68180-332-07. The dosage and use instructions are mentioned in the accompanying prescribing information, and the medication should be stored at 25°C (77°F) with excursions permitted to 15° to 30°C (59° to 86°F) [see USP Controlled Room Temperature]. The medication is manufactured by Lupin Limited in Pithampur (V.B) 454 775, INDIA and distributed in the US by Lupin Pharmaceuticals Inc. The label includes a warning that the medication should not be dispensed without providing the separate patient information leaflet.*

This is a description of Ziprasidone HCI capsules, containing 60 capsules, developed by Lupin Pharmaceuticals. The capsules are only to be dispensed by pharmacists and are labeled for patient use only. These capsules are made using ziprasidone hydrochloride monohydrate USP, with each capsule having an equivalent of 60 mg of ziprasidone. Although the dosage and use of these capsules are not stated, there is a prescription information guide that should be provided to the patient. These capsules should be stored in a controlled room temperature of 25°C or between 15°C to 30°C with particular storage instructions as per USP. The capsules are manufactured in India, and the aforementioned pharmaceutical company is based in Baltimore, Maryland.*

Ziprasidone HCI capsules are a prescription medicine containing ziprasidone hydrochloride monohydrate USP equivalent to 80 mg of ziprasidone. The capsules are manufactured by Lupin Limited and distributed by Lupin Pharmaceuticals, Inc. The recommended dosage and use are specified in the accompanying prescribing information. The capsules should be stored at 25°C (77°F) with excursions permitted to 15° to 30°C (59° to 86°F) in accordance with USP controlled room temperature regulations. Dispensing pharmacists are advised to provide the patient information leaflet separately to each patient.*